Research links hearing loss genes to specific ear cells

Inside the inner ear, a spiral structure called the cochlea converts sound into electrical signals. It contains dozens of specialised cell types, each with a different job. A study published in the American Journal of Human Genetics suggests that which of those cells goes wrong may determine what kind of hearing loss develops.

Researchers combined two large datasets to reach this conclusion. The first was genome-wide association data — genetic information collected across many thousands of people, flagging regions of DNA linked to hearing loss. The second was single-cell gene expression data, which records which genes are active in which individual cell types inside the cochlea. By mapping one onto the other, the team was able to ask: where, exactly, in the ear do the at-risk genes tend to switch on?

The answer divided hearing loss into two distinct biological pathways. Genes associated with sensory hearing loss — the kind that damages the hair cells that detect sound vibrations — showed concentrated activity in one set of cochlear cell types. Genes associated with metabolic hearing loss — which affects the cells that maintain the electrochemical environment the hair cells depend on — showed activity in a separate, largely non-overlapping set. The study found that these two forms of age-related hearing loss are not simply variations of the same underlying process, but appear to involve different cellular machinery.

Why the distinction matters

Age-related hearing loss is the most common sensory condition in older adults, affecting a significant portion of people over 65, according to the World Health Organisation. For decades, it has been treated as a broadly uniform condition. The distinction the researchers identified may help explain why some people lose the ability to hear high-pitched sounds first, while others experience broader, more diffuse decline — and why some respond to interventions that others do not.

The researchers reported that their approach — overlaying genetic risk signals onto cell-specific gene expression maps — provides a method that could be applied to other complex sensory conditions. It does not yet translate into a clinical test or treatment. What it offers, the study's authors noted, is a clearer map of the biological pathways involved, which is the necessary step before targeted therapies become possible.

For people with albinism, who face elevated risk of certain auditory and sensory conditions related to the role melanin-producing cells play inside the cochlea, research that distinguishes between cochlear cell types carries particular relevance. The stria vascularis — the metabolic layer of the cochlea — contains melanocytes, and its function is closely connected to pigmentation biology.

The findings remain at the level of genetic and cellular science. But the picture they draw is more precise than what existed before.